Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
Melamed
E
E
Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.
Zoldan
J
J
Friedberg
G
G
Ziv
I
I
Weizmann
A
A
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000523:psychology*; D011605:Psychoses, Substance-Induced / Q000209:etiology / Q000523:psychology; D012701:Serotonin / Q000502:physiology*
D000978:Antiparkinson Agents; D012701:Serotonin; D007980:Levodopa